IL-6 emerges as early sepsis indicator in high risk groups

IL-6 emerges as early sepsis indicator in high risk groups

A pioneering study presented today at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient groups, including neonates, children and pregnant women.

Study identifies promising biomarker for early sepsis detection in neonates, children and pregnant women

A study presented at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient groups, including neonates, children and pregnant women. This study is the first to evaluate IL-6's diagnostic performance in a real-world cohort across all three populations.

ESCMID Global 2025: IL-6 Outperforms Traditional Tests for Early Sepsis Detection

The post ESCMID Global 2025: IL-6 Outperforms Traditional Tests for Early Sepsis Detection appeared first on European Medical Journal.

UK researchers find promising biomarker for early sepsis detection...

Last Updated on April 12, 2025 by Team THIP New Delhi, April 12 (IANS) A team of UK researchers has found the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient groups, including neonates, children, and pregnant women. Sepsis, a life-threatening condition resulting from the immune […] The post UK researchers find promising biomarker for early sepsis detection appeared first…

UK researchers find promising biomarker for early sepsis detection

A team of UK researchers has found the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient groups, including neonates, children, and pregnant women.

Cutting-edge sepsis dashboard halves mortality rates, shortens patient stays

AdventHealth has developed a dashboard to help clinicians earlier identify the necessary practice changes to improve survival rates among sepsis patients.